Pazopanib in Patients With Localized RCC to Optimize Preservation of Renal Parenchyma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
A Phase II Study of Pazopanib in Patients With Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma
J Urol 2015 Aug 01;194(2)297-303, BI Rini, ER Plimack, T Takagi, P Elson, LS Wood, R Dreicer, T Gilligan, J Garcia, Z Zhang, J Kaouk, V Krishnamurthi, AJ Stephenson, A Fergany, EA Klein, RG Uzzo, DY Chen, SC CampbellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.